BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29747127)

  • 1. Wideband LGE MRI permits unobstructed viewing of myocardial scarring in a patient with an MR-conditional subcutaneous implantable cardioverter-defibrillator.
    Rahsepar AA; Collins JD; Knight BP; Hong K; Carr JC; Kim D
    Clin Imaging; 2018; 50():294-296. PubMed ID: 29747127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wideband late gadolinium enhanced magnetic resonance imaging for imaging myocardial scar without image artefacts induced by implantable cardioverter-defibrillator: a feasibility study at 3 T.
    Ranjan R; McGann CJ; Jeong EK; Hong K; Kholmovski EG; Blauer J; Wilson BD; Marrouche NF; Kim D
    Europace; 2015 Mar; 17(3):483-8. PubMed ID: 25336666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device artifact reduction for magnetic resonance imaging of patients with implantable cardioverter-defibrillators and ventricular tachycardia: late gadolinium enhancement correlation with electroanatomic mapping.
    Stevens SM; Tung R; Rashid S; Gima J; Cote S; Pavez G; Khan S; Ennis DB; Finn JP; Boyle N; Shivkumar K; Hu P
    Heart Rhythm; 2014 Feb; 11(2):289-98. PubMed ID: 24140812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Wideband Late Gadolinium Enhancement Cardiac Magnetic Resonance Imaging on Device-Related Artifacts in Different Implantable Cardioverter-Defibrillator Types.
    Singh A; Chen W; Patel HN; Alvi N; Kawaji K; Besser SA; Tung R; Zou J; Lang RM; Mor-Avi V; Patel AR
    J Magn Reson Imaging; 2021 Oct; 54(4):1257-1265. PubMed ID: 33742522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal Artifact Reduction in Cardiovascular MRI for Accurate Myocardial Scar Assessment in Patients With Cardiac Implantable Electronic Devices.
    Runge M; Ibrahim EH; Bogun F; Attili A; Mahani MG; Pang Y; Horwood L; Chenevert TL; Stojanovska J
    AJR Am J Roentgenol; 2019 Sep; 213(3):555-561. PubMed ID: 31120781
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality assessment of cardiac magnetic resonance myocardial scar imaging prior to ventricular arrhythmia ablation.
    Shah R; Sharma A; Assis F; De Vasconcellos HD; Alugubelli N; Pandey P; Akhtar T; Gasperetti A; Zhou S; Halperin H; Zimmerman SL; Tandri H; Kolandaivelu A
    Int J Cardiovasc Imaging; 2023 Feb; 39(2):411-421. PubMed ID: 36331683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Cardiac Magnetic Resonance Wideband Protocol in Patients With Implantable Cardioverter Defibrillators and Its Utility for Defining Scar.
    Singh A; Kawaji K; Goyal N; Nazir NT; Beaser A; O'Keefe-Baker V; Addetia K; Tung R; Hu P; Mor-Avi V; Patel AR
    Am J Cardiol; 2019 Apr; 123(8):1329-1335. PubMed ID: 30739658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ICD artifact burden on late gadolinium enhancement cardiac MR imaging in patients undergoing ventricular tachycardia ablation.
    Mesubi O; Ahmad G; Jeudy J; Jimenez A; Kuk R; Saliaris A; See V; Shorofsky S; Dickfeld T
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1274-83. PubMed ID: 24766563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of cardiovascular magnetic resonance with optimized myocardial scar detection in patients with cardiac implantable devices.
    Bhuva AN; Kellman P; Graham A; Ramlall M; Boubertakh R; Feuchter P; Hawkins A; Lowe M; Lambiase PD; Sekhri N; Schilling RJ; Moon JC; Manisty CH
    Int J Cardiol; 2019 Mar; 279():72-78. PubMed ID: 30642645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.
    Holtstiege V; Meier C; Bietenbeck M; Chatzantonis G; Florian A; Köbe J; Reinke F; Eckardt L; Yilmaz A
    J Cardiovasc Magn Reson; 2020 May; 22(1):35. PubMed ID: 32418537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators.
    Roca-Luque I; Van Breukelen A; Alarcon F; Garre P; Tolosana JM; Borras R; Sanchez P; Zaraket F; Doltra A; Ortiz-Perez JT; Prat-Gonzalez S; Perea RJ; Guasch E; Arbelo E; Berruezo A; Sitges M; Brugada J; Mont L
    Europace; 2020 Apr; 22(4):598-606. PubMed ID: 32101605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified wideband three-dimensional late gadolinium enhancement MRI for patients with implantable cardiac devices.
    Rashid S; Rapacchi S; Shivkumar K; Plotnik A; Finn JP; Hu P
    Magn Reson Med; 2016 Feb; 75(2):572-84. PubMed ID: 25772155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
    Alexandre J; Saloux E; Lebon A; Dugué AE; Lemaitre A; Roule V; Labombarda F; Champ-Rigot L; Gomes S; Pellissier A; Scanu P; Milliez P
    Europace; 2014 Feb; 16(2):220-6. PubMed ID: 24186956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of image quality of wideband single-shot late gadolinium-enhancement MRI in patients with a cardiac implantable electronic device.
    Schwartz SM; Pathrose A; Serhal AM; Ragin AB; Charron J; Knight BP; Passman RS; Avery RJ; Kim D
    J Cardiovasc Electrophysiol; 2021 Jan; 32(1):138-147. PubMed ID: 33146422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved late gadolinium enhancement MR imaging for patients with implanted cardiac devices.
    Rashid S; Rapacchi S; Vaseghi M; Tung R; Shivkumar K; Finn JP; Hu P
    Radiology; 2014 Jan; 270(1):269-74. PubMed ID: 24086074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators.
    Dickfeld T; Tian J; Ahmad G; Jimenez A; Turgeman A; Kuk R; Peters M; Saliaris A; Saba M; Shorofsky S; Jeudy J
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):172-84. PubMed ID: 21270103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Scott PA; Morgan JM; Carroll N; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):324-30. PubMed ID: 21493964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wideband black-blood late gadolinium enhancement imaging for improved myocardial scar assessment in patients with cardiac implantable electronic devices.
    Gut P; Cochet H; Caluori G; El-Hamrani D; Constantin M; Vlachos K; Sridi S; Antiochos P; Schwitter J; Masi A; Sacher F; Jaïs P; Stuber M; Bustin A
    Magn Reson Med; 2024 Jun; ():. PubMed ID: 38852175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.